Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $192.40M | $177.38M | $726.41M | $196.87M | $179.52M |
| Total Operating Revenue | $192.40M | $177.38M | $726.41M | $196.87M | $179.52M |
| Cost of Revenue | $44.16M | $36.41M | $149.75M | $40.30M | $34.28M |
| Gross Profit | $148.24M | $140.96M | $576.66M | $156.57M | $145.24M |
| Operating Expense | $136.37M | $136.34M | $557.47M | $167.50M | $132.09M |
| Selling and Admin Expenses | $91.81M | $93.94M | $368.76M | $101.61M | $91.80M |
| -Selling & Marketing Expense | $52.12M | $58.17M | $226.62M | $61.61M | $58.47M |
| -General & Admin Expense | $39.69M | $35.78M | $142.14M | $40.00M | $33.33M |
| Research & Development | $30.24M | $28.07M | $117.31M | $37.45M | $25.97M |
| Depreciation & Amortization & Depletion | $14.32M | $14.32M | $57.29M | $14.32M | $14.32M |
| -Depreciation & Amortization | $14.32M | $14.32M | $57.29M | $14.32M | $14.32M |
| Operating Profit | $11.86M | $4.63M | $19.19M | -$10.92M | $13.15M |
| Net Non-Operating Interest Income (Expense) | -$1.68M | -$1.77M | $5.29M | -$1.60M | $4.26M |
| Non-Operating Interest Income | $1.94M | $1.93M | $22.73M | $2.30M | $8.53M |
| Non-Operating Interest Expense | $3.10M | $3.18M | $14.61M | $3.37M | $3.65M |
| Total Other Finance Costs | $521,000.00 | $521,000.00 | $2.84M | $520,000.00 | $626,000.00 |
| Other Income (Expense) | -$7.63M | $2.14M | -$7.60M | $13.09M | -$7.88M |
| Special Income (Charges) | -$7.59M | $2.28M | -$983,000.00 | $13.26M | -$7.77M |
| -Less:Restructuring and Mergern & Acquisition | $1.66M | -$2.28M | – | – | $4.07M |
| -Gain on Sale Of Business | -$5.93M | – | – | – | – |
| Other Non-Operating Income (Expenses) | -$34,000.00 | -$135,000.00 | -$6.62M | -$172,000.00 | -$110,000.00 |
| Pretax Profit | $2.56M | $5.00M | $16.87M | $571,000.00 | $9.52M |
| Tax | -$2.10M | $2.08M | $9.84M | -$1.07M | $4.09M |
| Net Profit | $4.65M | $2.92M | $7.03M | $1.64M | $5.43M |
| Profit from Continuing Operations | $4.65M | $2.92M | $7.03M | $1.64M | $5.43M |
| Net Income to Parent Company | $4.65M | $2.92M | $7.03M | $1.64M | $5.43M |
| Net Income to Common Stockholders | $4.65M | $2.92M | $7.03M | $1.64M | $5.43M |
| Basic EPS | $0.12 | $0.07 | $0.16 | $0.04 | $0.12 |
| Diluted EPS | $0.12 | $0.07 | $0.16 | $0.04 | $0.12 |
| Other Operating Expenses | – | – | $14.11M | – | – |
| -Less:Impairment of Capital Assets | – | – | $0.00 | -$25.87M | $25.87M |
| -Less:Other Special Charges | – | – | $983,000.00 | $16.15M | -$22.17M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $1.24B | $1.21B | $1.26B | $1.26B | $1.30B |
| Total Current Assets | $615.22M | $514.96M | $547.97M | $547.97M | $562.75M |
| Cash and Cash Equivalents & Short-Term Investments | $251.03M | $202.18M | $238.42M | $238.42M | $246.33M |
| -Cash and Cash Equivalents | $205.88M | $144.31M | $158.55M | $158.55M | $147.59M |
| -Short Term Investments | $45.16M | $57.87M | $79.88M | $79.88M | $98.75M |
| Receivables | $132.42M | $125.64M | $124.07M | $124.07M | $115.27M |
| -Accounts Receivable | $132.42M | $125.64M | $124.07M | $124.07M | $115.27M |
| Inventory | $134.58M | $150.37M | $152.86M | $152.86M | $157.68M |
| Other Current Assets | $29.85M | $36.78M | $32.62M | $32.62M | $43.47M |
| Total Non-Current Assets | $628.76M | $693.57M | $716.94M | $716.94M | $734.83M |
| Net PPE | $175.20M | $175.69M | $182.47M | $182.47M | $191.65M |
| -Gross PPE | $326.08M | $320.40M | $320.17M | $320.17M | $324.32M |
| -Accumulated Depreciation | -$150.88M | -$144.71M | -$137.70M | -$137.70M | -$132.67M |
| Goodwill and Other Intangible Assets | $305.13M | $373.00M | $388.31M | $388.31M | $402.71M |
| -Goodwill | $19.64M | $19.77M | $20.21M | $20.21M | $20.32M |
| -Other Intangible Assets | $285.48M | $353.23M | $368.10M | $368.10M | $382.40M |
| Non-Current Deferred Assets | $124.60M | $122.12M | $123.85M | $123.85M | $120.19M |
| Other Non-Current Assets | $23.84M | $22.77M | $22.31M | $22.31M | – |
| Total Liabilities | $572.00M | $554.64M | $571.81M | $571.81M | $570.36M |
| Total Current Liabilities | $122.01M | $108.79M | $120.59M | $120.59M | $107.08M |
| Payables | $17.51M | $14.01M | $15.15M | $15.15M | $17.69M |
| -Accounts Payable | $17.51M | $14.01M | $15.15M | $15.15M | $17.69M |
| Current Accrued Expenses | $66.51M | $84.96M | $57.76M | $57.76M | $79.64M |
| Short-Term Debt and Capital Lease Obligation | $10.30M | $9.82M | $9.84M | $9.84M | $9.75M |
| -Current Capital Lease Obligation | $10.30M | $9.82M | $9.84M | $9.84M | $9.75M |
| Other Current Liabilities | $705,000.00 | – | – | – | – |
| Total Non-Current Liabilities | $449.99M | $445.85M | $451.22M | $451.22M | $463.29M |
| Long Term Debt and Capital Lease Obligation | $401.82M | $401.36M | $408.37M | $408.37M | $415.56M |
| -Long Term Debt | $363.12M | $367.66M | $372.19M | $372.19M | $376.72M |
| -Long Term Capital Lease Obligation | $38.70M | $33.71M | $36.18M | $36.18M | $38.84M |
| Non-Current Deferred Liabilities | $4.07M | $4.09M | $4.21M | $4.21M | $4.59M |
| Other Non-Current Liabilities | $44.10M | $40.40M | $38.64M | $38.64M | $43.14M |
| Total Equity | $671.98M | $653.89M | $693.11M | $693.11M | $727.21M |
| Stockholders' Equity | $671.98M | $653.89M | $693.11M | $693.11M | $727.21M |
| Capital Stock | $49,000.00 | $48,000.00 | $48,000.00 | $48,000.00 | $48,000.00 |
| -Common Stock | $49,000.00 | $48,000.00 | $48,000.00 | $48,000.00 | $48,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.09B | $1.07B | $1.06B | $1.06B | $1.05B |
| Retained Earnings | -$191.75M | -$196.41M | -$199.32M | -$199.32M | -$200.96M |
| Less: Treasury Stock | $227.01M | $227.01M | $176.57M | $176.57M | $125.54M |
| Gains/Losses Not Affecting Retained Earnings | $3.24M | $3.46M | $4.33M | $4.33M | $4.12M |
| Investments and Advances | – | – | – | – | $20.27M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $57.46M | $25.68M | $151.99M | $43.69M | $60.83M |
| Net cash flow from continuing operations | $57.46M | $25.68M | $151.99M | $43.69M | $60.83M |
| Net Income from Continuing Operations | $4.65M | $2.92M | $7.03M | $1.64M | $5.43M |
| Depreciation & Depletion & Amortization | $21.30M | $21.33M | $91.02M | $21.34M | $21.19M |
| Deferred Tax | $3.91M | $1.73M | $6.48M | -$3.74M | $8.07M |
| Other Non-Cash Items | $2.55M | -$2.27M | -$9.63M | -$3.75M | $4.57M |
| Change in Working Capital | $16.49M | -$11.57M | -$38.27M | $14.71M | -$19.25M |
| -Change in Receivables | -$10.51M | -$1.57M | -$10.74M | -$8.80M | -$897,000.00 |
| -Change in Inventory | $5.96M | $2.49M | -$27.57M | $4.82M | -$9.51M |
| -Change in Prepaid Assets | $4.92M | -$4.54M | -$1.21M | $12.70M | $1.47M |
| -Change in Payables and Accrued Expense | $15.05M | -$11.24M | $1.26M | $11.07M | -$4.48M |
| -Change in Other Current Liabilities | $1.07M | $3.29M | – | – | -$5.83M |
| Net cash flow from investing | $11.76M | $19.44M | $99.48M | $19.33M | $43.61M |
| Net Cash Flow from Continuing Investing Activities | $11.76M | $19.44M | $99.48M | $19.33M | $43.61M |
| Net PPE Purchase and Sale | -$1.34M | -$2.72M | -$15.33M | -$218,000.00 | -$3.87M |
| Net Business Purchase and Sale | $0.00 | -$335,000.00 | -$16.70M | $0.00 | $0.00 |
| Net Investment Purchase and Sale | $13.10M | $22.50M | $131.52M | $19.55M | $47.48M |
| Financing Cash Flow | -$7.65M | -$59.40M | -$369.63M | -$51.65M | -$257.48M |
| Net Cash Flow from Continuing Financing Activities | -$7.65M | -$59.40M | -$369.63M | -$51.65M | -$257.48M |
| Net Issuance Payments Of Debt | -$5.00M | -$5.00M | -$216.80M | -$5.00M | -$205.24M |
| Net Common Stock Issuance | $0.00 | -$50.05M | -$148.33M | -$48.25M | -$50.04M |
| Proceeds from Stock Option Exercised | $843,000.00 | $2,000.00 | $3.30M | $1.72M | $12,000.00 |
| Net Other Financing Charges | -$3.49M | -$4.36M | -$7.80M | -$126,000.00 | -$2.21M |
| Ending Cash Balance | $205.88M | $144.31M | $158.55M | $158.55M | $147.59M |
| Net Change in Cash | $61.57M | -$14.28M | -$118.15M | $11.37M | -$153.03M |
| Beginning Cash Balance | $144.31M | $158.55M | $276.77M | $147.59M | $300.48M |
| Effect of Exchange Rate Changes | $0.00 | $38,000.00 | -$77,000.00 | -$414,000.00 | $133,000.00 |
| Free Cash Flow | $56.12M | $22.96M | $136.66M | $43.47M | $56.96M |
| Gain/Loss from Continuing Operations | – | – | $983,000.00 | $0.00 | – |
No comments yet — be the first to weigh in on PCRX.